Most Recent
The Full Federal Court has shot down plumbing company Repipe’s appeal of a decision rejecting its innovation patents for a claimed computer-implemented invention, saying it only addressed issues in business operations rather than improving on computer technology.
Tech company Vehicle Management Systems has come up short in its third attempt to block competitor SARB Management Group's patent application for a magnetic parking overstay detector, with the Full Court rejecting claims that VMS' managing director should have been listed as the device's inventor.
A judge has allowed two a2 Milk trade marks to proceed to registration despite "legitimate uncertainty" created by IP Australia in a long-running intellectual property spat with competitor Lion Dairy & Drinks.
Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.
The Federal Court's decision that artificial intelligence can be listed on a patent application as the inventor has become an outlier, as the UK joins the US in rejecting what has become an international battle to claim AI inventorship.
Graphics design platform Canva has been conditionally granted further time to apply to patent an invention for generating websites, after IP Australia found its US patent attorneys had made an "error or omission" by failing to track expiration dates for registering the patent.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.
US-based chemical and materials technology company Cytec Industries has won its Federal Court challenge to a mining patent application by a unit of Ecolab, with the court finding the claims in the patent lacked support and sufficient disclosure.
The Federal Court has dealt US drug giant Merck Sharp & Dohme a devastating blow, overturning an "untenable" patent term extension which would have protected the monopoly of its multibillion-dollar Januvia and Janumet diabetes drugs beyond July 2o22.
A New Zealand-based association representing manuka honey beekeepers has lost its opposition to an application for the 'Australian Manuka' trade mark by a Byron Bay honey producer, with IP Australia finding the word 'manuka' did not specifically refer to honey made in NZ.